Wallace Thompson

Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast Cancer

Obi L. Griffith, Paul T. Spellman, Joe W. Gray, 2015, PloS one.

Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast Cancer

Laura M. Heiser, Nicholas J. Wang, C. Tomlin, 2015, PloS one.

Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer Subtypes

Joe W. Gray, Damir Sudar, Mark A. Dane, 2018, Cell systems.

Sensitivity to targeted therapy differs between HER2-amplified breast cancer cells harboring kinase and helical domain mutations in PIK3CA

Laura M. Heiser, K. Chin, J. Gray, 2021, Breast Cancer Research.